A detailed history of New York State Common Retirement Fund transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 33,501 shares of BLUE stock, worth $294,138. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,501
Previous 33,501 -0.0%
Holding current value
$294,138
Previous $33,000 48.48%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$0.85 - $1.26 $133,370 - $197,702
-156,907 Reduced 82.41%
33,501 $33,000
Q1 2024

May 07, 2024

SELL
$0.91 - $1.75 $252 - $484
-277 Reduced 0.15%
190,408 $244,000
Q4 2023

Feb 01, 2024

BUY
$1.32 - $4.83 $100,966 - $369,446
76,490 Added 66.98%
190,685 $263,000
Q3 2023

Nov 07, 2023

BUY
$3.02 - $4.05 $50,141 - $67,242
16,603 Added 17.01%
114,195 $347,000
Q2 2023

Aug 07, 2023

BUY
$2.79 - $5.03 $181,350 - $326,950
65,000 Added 199.44%
97,592 $321,000
Q1 2023

May 02, 2023

SELL
$3.14 - $8.22 $37,877 - $99,157
-12,063 Reduced 27.01%
32,592 $104,000
Q4 2022

Jan 30, 2023

BUY
$5.77 - $8.49 $219 - $322
38 Added 0.09%
44,655 $309,000
Q3 2022

Nov 08, 2022

BUY
$3.75 - $7.39 $506 - $997
135 Added 0.3%
44,617 $282,000
Q2 2022

Aug 04, 2022

SELL
$2.94 - $5.23 $326 - $580
-111 Reduced 0.25%
44,482 $184,000
Q1 2022

May 05, 2022

SELL
$4.07 - $10.6 $16,581 - $43,184
-4,074 Reduced 8.37%
44,593 $216,000
Q4 2021

Feb 02, 2022

SELL
$8.96 - $16.31 $1,370 - $2,495
-153 Reduced 0.31%
48,667 $486,000
Q3 2021

Nov 02, 2021

SELL
$11.24 - $21.0 $105,431 - $196,980
-9,380 Reduced 16.12%
48,820 $933,000
Q2 2021

Aug 02, 2021

SELL
$18.04 - $22.09 $221,892 - $271,707
-12,300 Reduced 17.45%
58,200 $1.86 Million
Q1 2021

May 11, 2021

SELL
$16.59 - $33.89 $1.76 Million - $3.6 Million
-106,342 Reduced 60.13%
70,500 $2.13 Million
Q4 2020

Feb 08, 2021

SELL
$27.5 - $37.92 $497,750 - $686,352
-18,100 Reduced 9.28%
176,842 $7.65 Million
Q3 2020

Nov 05, 2020

SELL
$34.44 - $43.75 $251,411 - $319,375
-7,300 Reduced 3.61%
194,942 $10.5 Million
Q2 2020

Aug 07, 2020

BUY
$27.12 - $45.97 $389,578 - $660,359
14,365 Added 7.65%
202,242 $12.3 Million
Q1 2020

May 06, 2020

BUY
$26.16 - $63.5 $577,795 - $1.4 Million
22,087 Added 13.32%
187,877 $8.64 Million
Q3 2019

Nov 07, 2019

SELL
$59.47 - $93.1 $130,834 - $204,820
-2,200 Reduced 1.31%
165,790 $15.2 Million
Q2 2019

Aug 09, 2019

SELL
$75.84 - $105.21 $102,384 - $142,033
-1,350 Reduced 0.8%
167,990 $21.4 Million
Q1 2019

May 08, 2019

SELL
$64.44 - $104.11 $38,664 - $62,466
-600 Reduced 0.35%
169,340 $26.6 Million
Q4 2018

Feb 08, 2019

BUY
$59.1 - $93.26 $1.16 Million - $1.83 Million
19,644 Added 13.07%
169,940 $16.9 Million
Q3 2018

Nov 07, 2018

SELL
$88.86 - $117.49 $1.28 Million - $1.7 Million
-14,429 Reduced 8.76%
150,296 $21.9 Million
Q2 2018

Aug 10, 2018

BUY
$99.64 - $127.59 $6.19 Million - $7.93 Million
62,137 Added 60.57%
164,725 $25.9 Million
Q1 2018

May 10, 2018

SELL
$105.8 - $150.94 $645,062 - $920,281
-6,097 Reduced 5.61%
102,588 $17.5 Million
Q4 2017

Feb 13, 2018

SELL
$81.25 - $130.7 $1.18 Million - $1.9 Million
-14,548 Reduced 11.81%
108,685 $19.4 Million
Q3 2017

Nov 06, 2017

SELL
$57.74 - $91.42 $1.44 Million - $2.29 Million
-25,021 Reduced 16.88%
123,233 $16.9 Million
Q2 2017

Aug 11, 2017

BUY
N/A
148,254
148,254 $15.6 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $677M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.